[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
[ Mon, Feb 27th 2023 ]: WOPRAI
Terence Flynn Maintained (CCCC) at Sell with Decreased Target to $5 on, Feb 27th, 2023
- 🞛 This publication is a summary or evaluation of another publication
Terence Flynn of Morgan Stanley, Maintained "C4 Therapeutics, Inc." (CCCC) at Sell with Decreased Target from $6 to $5 on, Feb 27th, 2023.
Terence has made no other calls on CCCC in the last 4 months.
There are 3 other peers that have a rating on CCCC. Out of the 3 peers that are also analyzing CCCC, 1 agrees with Terence's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Derek Archila of "Wells Fargo" Maintained at Hold with Decreased Target to $9 on, Tuesday, January 3rd, 2023
These are the ratings of the 2 analyists that currently disagree with Terence
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $35 on, Friday, February 24th, 2023
- Eric Joseph of "JP Morgan" Downgraded from Hold to Sell and Decreased Target to $5 on, Friday, February 24th, 2023